GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM102207
Query DataSets for GSM102207
Status
Public on Mar 30, 2006
Title
LS-60
Sample type
RNA
Source name
lung
Organism
Homo sapiens
Characteristics
Cancer
Extracted molecule
total RNA
Extraction protocol
Total RNA was isolated from lung squamous cell carcinoma samples according to Standard Trizol protocol.
Label
biotin
Label protocol
Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.
Hybridization protocol
standard Affymetrix procedures
Scan protocol
standard Affymetrix procedures
Description
lung squamous carcinoma
Data processing
Affymetrix Microarray Suite version 5.0
Submission date
Mar 29, 2006
Last update date
Mar 29, 2006
Contact name
Jack Yu
E-mail(s)
jyu9@VRXUS.jnj.com
Phone
858-320-3362
Fax
858-784-3182
Organization name
Veridex, LLC
Street address
3210 Merryfield Row
City
San Diego
State/province
CA
ZIP/Postal code
92121
Country
USA
Platform ID
GPL96
Series (1)
GSE4573
Gene expression signatures for predicting prognosis of squamous cell lung carcinomas
Data table header descriptions
ID_REF
VALUE
MAS5-calculated Signal intensity after global scaling the average intensity to 600.
Data table
ID_REF
VALUE
AFFX-BioB-5_at
477.6
AFFX-BioB-M_at
723.5
AFFX-BioB-3_at
316.2
AFFX-BioC-5_at
1614.4
AFFX-BioC-3_at
1452.2
AFFX-BioDn-5_at
2583.3
AFFX-BioDn-3_at
7688.1
AFFX-CreX-5_at
15474.6
AFFX-CreX-3_at
19428.9
AFFX-DapX-5_at
41.4
AFFX-DapX-M_at
49.9
AFFX-DapX-3_at
22.4
AFFX-LysX-5_at
4.6
AFFX-LysX-M_at
71.2
AFFX-LysX-3_at
73.6
AFFX-PheX-5_at
9.4
AFFX-PheX-M_at
6
AFFX-PheX-3_at
50.6
AFFX-ThrX-5_at
18.5
AFFX-ThrX-M_at
51.8
Total number of rows:
22283
Table truncated, full table size
362 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|